Use the search parameters below to filter talks:

Calendar
Calendar

2009 - IPITA-IXA Joint Meeting (Venice)

PIG TO PRIMATE 1
15 October 2009  /  16:00 - 18:00

Prolonged survival of GaIT-KO swine skin on baboons

Presenter: J. I. Weiner, Boston, USA

- Prolonged survival of GaIT-KO swine skin on baboons

Presenter: J. I. Weiner, Boston, USA

-
15 September 2010  /  18:00 - 00:00

IXA PRESIDENTIAL ADDRESS

Presenter: R. N. Pierson, Baltimore, USA

- IXA PRESIDENTIAL ADDRESS

Presenter: R. N. Pierson, Baltimore, USA

Presentation of IXA Honorary Membership

Presenter: D.K.C. Cooper, Pittsburgh, USA

- Presentation of IXA Honorary Membership

Presenter: D.K.C. Cooper, Pittsburgh, USA

ISLET IMAGING
13 October 2009  /  08:00 - 08:00

Functional imaging of islet mass

Presenter: W. Malaisse, Brussels, Belgium

- Functional imaging of islet mass

Presenter: W. Malaisse, Brussels, Belgium

MRI imaging of grafted allogenic islets in transplant patients

Presenter: C. Toso, Geneva, Switzerland

- MRI imaging of grafted allogenic islets in transplant patients

Presenter: C. Toso, Geneva, Switzerland

PET imaging of islet transplant recipients

Presenter: T. Lundgren, Uppsala, Sweden

- PET imaging of islet transplant recipients

Presenter: T. Lundgren, Uppsala, Sweden

LATE ISLET GRAFT FAILURE
13 October 2009  /  14:15 - 15:45

Monitoring islet destruction

Presenter: T. Berney, Geneva, Switzerland

- Monitoring islet destruction

Presenter: T. Berney, Geneva, Switzerland

PATHOLOGY AND CLINICAL MANAGEMENT OF THE HYPERIMMUNIZED PATIENT
14 October 2009  /  14:00 - 17:15

Antibody-mediated rejection: new biological markers

Presenter: J.P Souillou, Nantes, France

- Antibody-mediated rejection: new biological markers

Presenter: J.P Souillou, Nantes, France

Use of intravenous immoglobulin and Rituximab for the prevention and treatment of antibobymediated rejection

Presenter: S. Jordan, Los Angeles, USA

- Use of intravenous immoglobulin and Rituximab for the prevention and treatment of antibobymediated rejection

Presenter: S. Jordan, Los Angeles, USA

NEW APPROACHES IN ISLET XENOTRANSPLANTATION
15 October 2009  /  08:00 - 09:00

New immunosuppressive protocols for islet xenotransplantation

Presenter: G. Rayat, Edmonton, Canada

- New immunosuppressive protocols for islet xenotransplantation

Presenter: G. Rayat, Edmonton, Canada

GUIDELINES FOR CLINICAL TRIALS
16 October 2009  /  14:45 - 15:45

Inventory of xenotransplantation practices

Presenter: L. Buehler, Geneva, Switzerland

- Inventory of xenotransplantation practices

Presenter: L. Buehler, Geneva, Switzerland

Submission of an application of a clinical trial of xenotransplantation to the health authorities

Presenter: R.B. Elliott, Manukau, New Zealand

- Submission of an application of a clinical trial of xenotransplantation to the health authorities

Presenter: R.B. Elliott, Manukau, New Zealand

ISLET ENGRAFTMENT
12 October 2009  /  14:15 - 15:45

Bone marrow as an alternative site for islet transplantation

Presenter: E. Cantarellil, Milan, Italy

- Bone marrow as an alternative site for islet transplantation

Presenter: E. Cantarellil, Milan, Italy

Prevention of non-immunologic loss of transplanted islets in monkeys

Presenter: M. Koulmanda, Boston, USA

- Prevention of non-immunologic loss of transplanted islets in monkeys

Presenter: M. Koulmanda, Boston, USA

Role of chemokines during IBMIR and development of new therapeutic target

Presenter: S. Sigrist, Strasbourg, France

- Role of chemokines during IBMIR and development of new therapeutic target

Presenter: S. Sigrist, Strasbourg, France

Quantification of transplanted iron oxide-labeled islet cell by 3-dimensional 3T magnetic resonance imaging (MRI)

Presenter: F. Ris, Geneve, Switzerland

- Quantification of transplanted iron oxide-labeled islet cell by 3-dimensional 3T magnetic resonance imaging (MRI)

Presenter: F. Ris, Geneve, Switzerland

A strong candidate approach to prevent the instant blood-mediated inflammatory reaction in clinical isIet transplantation

Presenter: K. Tokodai, Sendai, Japan

- A strong candidate approach to prevent the instant blood-mediated inflammatory reaction in clinical isIet transplantation

Presenter: K. Tokodai, Sendai, Japan

Testis specific gene as novel tool for detection of islet damage in the peripheral blood of mice with a portal islet transplant

Presenter: L.J. Wang, Chicago, USA

- Testis specific gene as novel tool for detection of islet damage in the peripheral blood of mice with a portal islet transplant

Presenter: L.J. Wang, Chicago, USA

A small molecular GPR119 agonist stimulates beta cell replication and improves islet graft function

Presenter: J. G. Gao, Minneapolis, USA

- A small molecular GPR119 agonist stimulates beta cell replication and improves islet graft function

Presenter: J. G. Gao, Minneapolis, USA

METABOLIC AND TRANSPLANT SURGERY FOR TYPE II DIABETES
13 October 2009  /  14:15 - 15:45

Introduction: Does surgery for T2D make sense?

Presenter: S. Bartlett, Baltimore, USA

- Introduction: Does surgery for T2D make sense?

Presenter: S. Bartlett, Baltimore, USA

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi